‘Local Recurrence’ and ‘Disease-Free Survival’

REFERENCES

• ABRATT RP, CRAIGHEAD, PS, REDDI, VB, SAREMBOCK, LA. Radical irradiation for carcinoma of the prostate. S Afr Med J 1990; 78: 309–311.
   PubMedGoogle Scholar
• ASBELL SO, MARTZ KL, PILEPICH MV, BAER-WALD HH, SAUSE WT, DOGGET RL, PEREZ, CA. Impact of surgical staging in evaluating the radiotherapeutic outcome in RTOG phase III study for A2 and B prostate carcinoma. Int J Radiation Oncology Biol Phys 1989; 17: 945–951.
   PubMed Web of Science ®Google Scholar
• BAGSHAW, MA, COX, RS, RAY GR. Status of radiation treatment of prostate cancer at Stanford University. NCI Monogr 1988; 7: 47–60.
   Google Scholar
• BLUTE ML, ZINCKE H, FARROW GM, THERNEAU T, LIEBER MM. Pattern of failure after radical retropubic prostatectomy for clinically and pathologically localized adenocarcinoma of the prostate: influence of tumor deoxyribonucleic acid ploidy. J Urol 1989; 142: 1262–1265.
   PubMed Web of Science ®Google Scholar
• BRAUSI M, SOLOWAY M. Progression and complications after external beam radiation therapy for carcinoma of prostate. Urology 1989; 34: 115–119.
   PubMed Web of Science ®Google Scholar
• BYAR DP, ANDERSON J, BLUMENSTEIN B, GIBBONS RP, LEPOR H, OLSSON CA, SIMON R. Guidelines for reporting studies of treatment of prostatic cancer. In: Coffey, Resnick MI, Dorr FA, Karr JP (eds), A multidisciplinary analysis of controversies in the management of prostate cancer. Plenum press, New York and London, 1988, pp 309–320.
   Google Scholar
• GIBBONS, RP, CORREA RJ, BRANNEN GE, WEISSMAN RM. Total prostatectomy for clinically localized prostatic cancer: long-term results. J Urol 1989; 141: 564–566.
   PubMedGoogle Scholar
• HANKS GE, MARTZ KL, KRALL JM, DIAMOND JJ. Analysis of independent variables affecting survival after recurrence of prostate cancer. Int J Radiation Oncology Biol Phys 1989; 16: 1431–1435.
   PubMedGoogle Scholar
• HANKS GE, DIAMOND JJ, KRALL JM, MARTZ KL, KRAMER S. A ten year follow-up of 682 patients treated for prostate cancer with radiation therapy in the United States. 1987; 13: 499–505.
   Google Scholar
• HANKS GE, LIEBEL SA, KRALL JM, KRAMER S. Patterns of care studies: dose-response observations for local control of adenocarcinoma of the prostate. Int J Radiation Oncology Biol Phys 1985; 11: 153–157.
   PubMed Web of Science ®Google Scholar
• HANKS GE, KRALL JM, MARTZ KL, DIAMOND JJ, KRAMER S. The outcome of treatment of 313 patients with T-1 (UICC) prostate cancer treated with external beam irradiation. Int J Radiation Oncology Biol Phys 1988; 14: 243–248.
   PubMed Web of Science ®Google Scholar
• KUBAN DA, EL-MAHDI AM, SCHELLHAMMER PF. Effects of local tumor control on distant metastasis and survival in prostatic adenocarcinoma. Urologv 1987; 30: 420–426.
   PubMedGoogle Scholar
• KUBAN DA, EL-MAHDI AM, SCHELLHAMMER PF. Prognosis in patients with local recurrence after definitive irradiation for prostatic carcinoma. Cancer 1989; 63: 2421–2425.
   PubMedGoogle Scholar
• LEPOR H, KIMBALL AW, WALSH PC. Cause-specific actuarial survival analysis: a useful method for reporting survival data in men with clinically localized carcinoma of the prostate. J Urol 1989; 141: 82–84.
   PubMedGoogle Scholar
• LEONARD K, STRYKER J. Radiotherapy for prostate carcinoma. J Surg Oncol 1986; 33: 1–7.
   PubMedGoogle Scholar
• MIDDLETON RG, SMITH JA, MELZER RB, HAMILTON PE. Patient survival and local recurrence rate following radical prostatectomy for prostatic carcinoma. J Urol 1986; 136: 422–424.
   PubMed Web of Science ®Google Scholar
• MUKAMEL E, DEKERNION JB, DOREY F, HANNAH J. Significance of histological prognostic indicators in patients with carcinoma of the prostate. Br J Urol 1990; 65: 46–50.
   PubMedGoogle Scholar
• NILSSON I, LINDHOLM CE, LANDBERG T, ABRAHAMSSON P-A, SUNDQVIST L, LINDHOLM K. Radical radiotherapy in prostatic carcinoma. Acta Oncol 1989; 28: 261–266.
   PubMed Web of Science ®Google Scholar
• PAULSON DF, MOUL JW, WALTHER PJ. Radical prostatectomy for clinical stage T1-2N0M0 prostatic adenocarcinoma: Long-term results. J Urol 1990; 144: 1180–1184.
   PubMed Web of Science ®Google Scholar
• PEREZ CA, PILEPICH MV, ZIVNUSKA F. Tumor control in definitive irradiation of localized carcinoma of the prostate. Int J Radiation Oncology Biol Phys 1986; 12: 523–531.
   PubMed Web of Science ®Google Scholar
• PILEPICH MV, KRALL JM, JOHNSON RJ, SAUSE WT, PEREZ CA, ZINNIGER M, MARTZ K. Extended field (periaortic) irradiation in carcinoma of the prostate - analysis of RTOG 75–06. Int J Radiation Oncology Biol Phys 1986; 12: 345–351.
   PubMed Web of Science ®Google Scholar
• RESNICK MI, BAGSHAW, MA, DORR FA, GARNICK MB, HORTON J, PROUT G, STAMEY TA, SCARDINO, PT. Response/progression criteria for evaluating prostate cancer. In: Coffey, Resnick MI, Dorr FA, Karr JP (eds). A multidisciplinary analysis of controversies in the management of prostate cancer. Plenum press, New York and London, 1988, pp 299–308.
   Google Scholar
• RITCHIE AWS, DOREY F, LAYFIELD LJ, HANNAH J, LOVREKOVICH H, DEKERNION JB. Relationship of DNA content to conventional prognostic factors in clinically localised carcinoma of the prostate. Br J Urol 1988; 62: 254–260.
   Google Scholar
• ROUNSAVILLE MC, GREEN JP, VAETH JM, PURDON RP, HELTZEL MM. Prostatic carcinoma: Limited field irradiation. Int J Radiation Oncology Biol Phys 1987; 13: 1013–1020.
   PubMedGoogle Scholar
• SAGERMAN RH, CHUN HC, KING GA, CHUNG CT, DALAL PS. External beam radiotherapy for carcinoma of the prostate. Cancer 1989; 63: 2468–2474
   PubMed Web of Science ®Google Scholar
• SCHELLHAMMER PF. Radical prostatectomy. Patterns of local failure and survival in 67 patients. Urology 1988; 31: 191–197.
   PubMed Web of Science ®Google Scholar
• ZAGARS GK, VON ESCHENBACH AC, JOHNSON DE, OSWALD MJ. The role of radiation therapy in stages A2 and B adenocarcinoma of the prostate. Int J Radiation Oncology Biol Phys 1988; 14: 710–709.
   Google Scholar